Research supports that iron dysregulation may drive AMD Posted on October 28, 2025January 15, 2026 by edgover
PulseSight Therapeutics Publishes Data Supporting Transferrin Therapy for Dry AMD and Geographic Atrophy Posted on October 15, 2025January 15, 2026 by edgover
PulseSight Therapeutics Builds Non-Viral Gene Therapy Pipeline For AMD Posted on September 15, 2025January 15, 2026 by fowlerat
Study Connects Iron Regulation and Vision Loss Posted on September 5, 2025January 21, 2026 by edgover
Study Connects Iron Regulation and Vision Loss Posted on September 4, 2025January 15, 2026 by edgover
PulseSight to highlight new data on the role of iron and transferrin in AMD at EURETINA 2025 Posted on September 4, 2025January 15, 2026 by edgover
PulseSight Therapeutics to Present New Data on Iron Dysregulation and Ferroptosis in AMD at Euretina 2025 Posted on September 4, 2025January 15, 2026 by edgover
A new treatment for dry AMD and tackling peanut allergies Posted on August 15, 2025January 15, 2026 by fowlerat
PulseSight doses first subject in Phase I trial of dry AMD/GA therapy Posted on July 8, 2025January 15, 2026 by edgover
